SMMT
Summit Therapeutics Inc
$1.97
Earnings Summary
Net Profits | $-21.27Mn |
Highlights
Net Profits:
Summit Therapeutics Inc’s net profit jumped 17.66% since last year same period to $-21.27Mn in the Q4 2023. On a quarterly growth basis, Summit Therapeutics Inc has generated -44.51% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Summit Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.26 |
EPS Estimate Current Year | -0.26 |
Highlights
EPS Estimate Current Quarter:
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.26 - a 0% jump from last quarter’s estimates.
EPS Estimate Current Year:
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.26.
Key Ratios
Key ratios of the Summit Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.03 |
Highlights
Earning Per Share (EPS):
Summit Therapeutics Inc’s earning per share (EPS) jumped 78.57% since last year same period to -0.03 in the Q4 2023. This indicates that the Summit Therapeutics Inc has generated 78.57% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-03-09 | -0.26 | -0.07 | 73.08% |
₹0 US Stocks a/c Opening Fee